Has Vody Vincent received payments from drug or device companies?

Yes. Drug and device makers reported $5,125 in general payments to Vody Vincent across 266 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vody Vincent did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vody Vincent come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vody Vincent

Psychiatric/Mental Health · Union, NJNPI 1013059575

Payments from drug & device makers

$5,125in general payments, 2019–2025

Across 266 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$1K
Teva Pharmaceuticals USA, Inc.$788
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$689
Johnson & Johnson$633
AbbVie$610
Lundbeck LLC$313
plus $840 from 9 others

What the payments were for

Food & beverage$5,125100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	60	$1,252
Teva Pharmaceuticals USA, Inc.	52	$788
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	33	$689
Johnson & Johnson	24	$633
AbbVie	31	$610
Lundbeck LLC	19	$313
Vanda Pharmaceuticals Inc.	16	$227
Supernus Pharmaceuticals, Inc.	5	$183
Otsuka America Pharmaceutical, Inc.	9	$143
Neurocrine Biosciences, Inc.	7	$118
Axsome Therapeutics, Inc.	3	$60
Ironshore Pharmaceuticals Inc.	3	$45
Sunovion Pharmaceuticals Inc.	2	$34
Tris Pharma Inc	1	$15
Indivior Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,125 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	75	$11,275
Quetiapine Fumarate	124	$1,922
Divalproex Sodium	35	$509
Mirtazapine	63	$438
Risperidone	45	$358
Bupropion XlBupropion Hcl	20	$235
Paroxetine Hcl	11	$223
Buspirone Hcl	23	$217
Duloxetine Hcl	20	$216
Lamotrigine	40	$214
Olanzapine	11	$149
Trazodone Hcl	51	$143
Escitalopram Oxalate	30	$115
Sertraline Hcl	59	$107
Benztropine Mesylate	13	$99

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Union

Kevin ObiUnion$11K
Ubong UdofiaMarlton$407K
Anthony DimuraRed Bank$130K
Amy PinsenNewton$111K
Aaron SpectorMarlton$100K
Fiorella ParadisiSparta$84K
Diane BurtBridgeton$81K
Alta ManessHackensack$75K
Laura LeahySewell$41K
Linda WinfulMontclair$40K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →